Literature DB >> 23359235

Association of inhibitors of gastric acid secretion and higher incidence of necrotizing enterocolitis in preterm very low-birth-weight infants.

Kiran More1, Gayatri Athalye-Jape, Shripada Rao, Sanjay Patole.   

Abstract

BACKGROUND: Inhibitors of gastric acid (IGA) are used for upper gastrointestinal bleeding or gastroesophageal reflux in preterm infants. The resultant increase in gastric pH may enhance the growth of pathogens and increase the risk of necrotizing enterocolitis (NEC). Our systematic review examined the association between IGA and NEC in preterm infants.
METHODS: Standard methodology of systematic reviews was followed. PubMed, Embase, Cochrane, and Cumulative Index to Nursing and Allied Health Literature (CINAHL) databases were searched in August 2012.
RESULTS: One case-control and one prospective cohort study (n = 11,346), both evaluating H2-blockers as IGA, were included. Meta-analysis showed a significant association between NEC and IGA (odds ratio [OR]: 1.78, 95% confidence interval [CI]: 1.4, 2.27, p < 0.00001). The prospective cohort study found higher incidence of infection (sepsis, pneumonia, urinary tract infection) with IGA (37.4% versus 9.8%, OR: 5.5, 95% CI: 2.9 to 10.4, p < 0.001).
CONCLUSIONS: Exposure to H2 receptor antagonists may be associated with increased risk of NEC and infections in preterm infants. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23359235     DOI: 10.1055/s-0033-1333671

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  19 in total

Review 1.  A critical analysis of risk factors for necrotizing enterocolitis.

Authors:  Allison Thomas Rose; Ravi Mangal Patel
Journal:  Semin Fetal Neonatal Med       Date:  2018-08-01       Impact factor: 3.926

Review 2.  Dietary intake and bio-activation of nitrite and nitrate in newborn infants.

Authors:  Jesica A Jones; Andrew O Hopper; Gordon G Power; Arlin B Blood
Journal:  Pediatr Res       Date:  2014-10-14       Impact factor: 3.756

Review 3.  New insights into necrotizing enterocolitis: From laboratory observation to personalized prevention and treatment.

Authors:  David J Hackam; Chhinder P Sodhi; Misty Good
Journal:  J Pediatr Surg       Date:  2018-06-18       Impact factor: 2.545

4.  Selective Proteolysis of α-Lactalbumin by Endogenous Enzymes of Human Milk at Acidic pH.

Authors:  Junai Gan; Jingyuan Zheng; Nithya Krishnakumar; Elisha Goonatilleke; Carlito B Lebrilla; Daniela Barile; J Bruce German
Journal:  Mol Nutr Food Res       Date:  2019-07-16       Impact factor: 5.914

5.  Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.

Authors:  Daniel Stephen Green; Mohamed E Abdel-Latif; Lisa J Jones; Kei Lui; David A Osborn
Journal:  Cochrane Database Syst Rev       Date:  2019-07-02

Review 6.  Spontaneous intestinal perforation (SIP) will soon become the most common form of surgical bowel disease in the extremely low birth weight (ELBW) infant.

Authors:  Jonathan R Swanson; Amy Hair; Reese H Clark; Phillip V Gordon
Journal:  J Perinatol       Date:  2022-02-17       Impact factor: 2.521

Review 7.  Pathogenesis of NEC: Role of the innate and adaptive immune response.

Authors:  Timothy L Denning; Amina M Bhatia; Andrea F Kane; Ravi M Patel; Patricia W Denning
Journal:  Semin Perinatol       Date:  2016-12-09       Impact factor: 3.300

8.  Safety and efficacy of probiotic administration to preterm infants: ten common questions.

Authors:  Mark A Underwood; Erin Umberger; Ravi M Patel
Journal:  Pediatr Res       Date:  2020-08       Impact factor: 3.756

Review 9.  Human breast milk and the gastrointestinal innate immune system.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

10.  The complete blood cell count in a refined cohort of preterm NEC: the importance of gestational age and day of diagnosis when using the CBC to estimate mortality.

Authors:  P V Gordon; J R Swanson; R Clark; A Spitzer
Journal:  J Perinatol       Date:  2015-11-12       Impact factor: 2.521

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.